What You Should Know:
- Owkin, an AI-biotech company specializing in precision medicine, and Proscia, a leader in AI-enabled pathology solutions, have announced a strategic partnership to improve MSI testing for colorectal cancer (CRC). This collaboration aims to enhance the efficiency and accessibility of MSI screening, ultimately leading to better patient outcomes.
- Beyond MSI testing, Owkin and Proscia plan to collaborate on developing and commercializing additional AI solutions
Read More
Proscia
Fimlab to Deploy Proscia’s AI-Enabled Digital Pathology Platform
What You Should Know:
- Fimlab Laboratories, a provider of laboratory services, research, and training, has announced a partnership with Proscia, a global leader in AI-enabled pathology solutions.
- This collaboration will leverage Proscia's software platform to enhance Fimlab's digital pathology capabilities and drive more precise results.
The Benefits of Digital Pathology
Digital pathology is transforming the way pathologists analyze tissue samples. By transitioning to
Read More
QDx Pathology Services Deploys Proscia’s Pathology Platform To Improve Speed & Precision
What You Should Know:
QDx Pathology Services, an independent anatomical, molecular, and clinical pathology laboratory serving medical professionals and facilities throughout the United States, is working with Proscia®, a leading provider of digital and computational pathology solutions, to innovate its practice.The laboratory has deployed Proscia’s software to enable its pathologists to work faster and more confidently.
Revolutionizing Pathology: Proscia's Digital Solutions
Read More
FDA Clears Proscia’s Digital Pathology Solution for Cancer Diagnosis
What You Should Know:
Proscia, a leading provider of digital and computational pathology solutions, has received 510(k) clearance from the United States (U.S.) Food and Drug Administration (FDA) for its Concentriq® AP-Dx*. The digital pathology solution was cleared for the purpose of primary diagnosis.Proscia’s Concentriq AP-Dx is a comprehensive diagnostic software solution that immerses pathologists in an intuitive experience for viewing, interpreting, and managing whole slide images
Read More
Spectrum Taps Proscia to Modernize its Pathology Operations
- Proscia®, a leading provider of digital and computational pathology solutions, today announced that Spectrum Healthcare Partners (SHCP), an independent, multispecialty, physician-owned healthcare practice, has selected Concentriq® Dx to modernize its pathology operations. In adopting Proscia’s software platform, SHCP will increase access to high-quality diagnostic services across Maine and New Hampshire, better informing treatment decisions for more patients.
- Digital pathology, which
Read More
PathGroup Expands Operations with Proscia Concentriq Dx
What You Should Know:
- PathGroup, one of the largest providers of anatomic, clinical, digital, and molecular pathology services in the United States, is expanding its operations with Proscia's software platform (Concentriq® Dx) to further enhance the delivery of faster, higher quality results for millions of patients, helping to better inform treatment decisions.
- PathGroup currently supports more than 15,000 referring physicians and over 200 hospital
Read More
Develop, Partner, Acquire or Avoid – Where’s Investment for Digital Pathology Headed in 2023?
News of Fujifilm’s recent acquisition of software provider Inspirata’s digital pathology assets was met with much interest last month, following on from robust industry debate at Global Engage’s Digital Pathology and AI Congress: Europe a few weeks prior. Their discussions centered around the progress of the market and its inevitable future developments.
Whilst our in-depth analysis of the implications of Fujifilm’s specific deal will be released soon as a part of our Premium Insights
Read More
Netherlands Cancer Institute to Deploy Proscia’s Pathology Platform
What You Should Know:
- Proscia®, a provider of digital and computational pathology solutions, announced that the Netherlands Cancer Institute (NKI), one of the top 10 comprehensive cancer centers in Europe, will deploy its Concentriq® Dx platform.
- NKI is transitioning to Concentriq Dx to expand its digital pathology practice, laying the foundation for its pathologists to deliver personalized diagnoses that better inform treatment decisions. In doing so, the cancer center,
Read More
Research: Proscia AI Predicts Diagnostic Agreement for Melanoma
What You Should Know:
- Proscia® a provider of digital and computational pathology solutions, has released study results on new artificial intelligence (AI) that predicts diagnostic agreement for melanoma, the deadliest form of skin cancer.
- The findings, which were presented at the European Conference on Computer Vision (ECCV) 2022, highlight the potential of the technology to improve diagnostic accuracy for melanoma and other diseases with low pathologist concordance.
Findings
Read More
Proscia Unveils New Enhancements to its Digital Pathology Platform
What You Should Know:
- Proscia®, a leading provider of digital and computational pathology solutions, has introduced the next version of its Concentriq® Dx platform for primary diagnostic workflows, which is CE-marked under IVDR.
- The release brings together new features and a compelling user experience to help even the largest laboratory networks transition to 100% digital diagnosis. In doing so, they can realize the full promise of the shift away from microscope-based
Read More
